Abeona therapeutics announces the appointment of michael amoroso as chief operating officer

New york and cleveland, oct. 27, 2020 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced that michael amoroso, senior vice president and chief commercial officer at abeona, has been promoted to chief operating officer and will serve as the company's principal executive and operating officer, effective november 1, 2020. in this newly created role at abeona, mr. amoroso's responsibilities will broaden to include oversight and leadership of all operations; including but not limited to, research and clinical development, regulatory, medical, commercial, corporate affairs and business development.
ABEO Ratings Summary
ABEO Quant Ranking